Neurodawn Pharmaceutical Co., Ltd.

This completed Phase 1 trial studied whether Y-3 for injection changes how the body processes three common drugs (repaglinide, warfarin, and omeprazole) in 24 healthy Chinese adults. Participants took these drugs with and without Y-3 to measure blood levels and safety. The goal i…

This early-stage study tested the safety and how the body handles a new drug called Y-3 in 20 healthy adults. Participants received a single dose of 40 mg, 60 mg, or a placebo. The goal was to measure drug levels in the blood and check for any side effects, not to treat a disease…